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Yeast glutaredoxin 3 (Grx3) is a cytosolic protein that
regulates the activity of the iron-responsive transcriptional
activator Aft1. This member of the monothiol glutaredoxin
family contains a thioredoxin-like domain and a glutaredoxin-
like domain, which both possess a monothiol active site. The
crystal structure of the thioredoxin-like domain has been
determined at 1.5 Å resolution and represents the first
published structure of this domain for the monothiol
glutaredoxin family. The loop containing the signature motif
WAxxC is partially disordered, indicating a greater degree of
flexibility in this region compared with classical dithiol
thioredoxins with a WCGPC active-site motif.
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1. Introduction
Thioredoxins (Trxs) and glutaredoxins (Grxs) are small
oxidoreductases (usually 9–15 kDa) that are found in all types
of organisms. Both proteins are members of the thioredoxin-
fold superfamily and typically catalyze thiol–disulfide
exchange reactions. The classical dithiol Trxs utilize a highly
conserved WCGPC active-site motif to reduce disulfides in
substrate proteins. The dithiol Grxs possess a CPYC active-
site motif and primarily catalyze glutathionylation and
deglutathionylation of target proteins (Berndt et al., 2008). A
subfamily of Grxs were recently identified that are char-
acterized by a conserved monothiol CGFS active-site motif
(Herrero & de la Torre-Ruiz, 2007). Saccharomyces cerevisiae
has three Grx-like proteins that belong to this subclass: yGrx3,
yGrx4 and yGrx5. yGrx5 contains a single Grx-like domain
and is localized to the mitochondrial matrix, where it plays an
ill-defined role in Fe–S cluster biogenesis (Rodriguez-
Manzaneque et al., 2002). However, recent evidence from
studies of yGrx5 homologues in chloroplasts suggest that this
protein may act as a scaffold for Fe–S cluster assembly and
transfer (Bandyopadhyay et al., 2008). Homologues of yGrx5
with a single Grx-like domain are found in both prokaryotes
and eukaryotes (Herrero & de la Torre-Ruiz, 2007).
Yeast Grx3 and Grx4 are highly homologous proteins that
possess both an N-terminal Trx-like domain and a C-terminal
Grx-like domain (Herrero & de la Torre-Ruiz, 2007). Both
proteins are cytosolic and are required for iron-responsive
inhibition of the transcriptional activator Aft1 (Kumanovics et
al., 2008; Ojeda et al., 2006; Pujol-Carrion et al., 2006). The
conserved cysteine in the CGFS active site located in the Grx-
like domain of yGrx3 and yGrx4 is required for interaction
with Aft1 and regulation of its activity (Ojeda et al., 2006). The
Trx-like domains have a WAxPC motif in place of the signa-
ture WCGPC active-site motif found in classical dithiol Trxs.
Monothiol Grxs with this hybrid Trx-Grx domain architecture
are only found in eukaryotes (Herrero & de la Torre-Ruiz,
2007). In general, the Grx-like domains of this protein family
are more highly conserved than the Trx-like domains (Isakov
et al., 2000). The human homologue of yGrx3/4 (termed
PICOT for PKC-interacting cousin of Trx) has an N-terminal
Trx-like domain followed by two Grx-like domains (Isakov et
al., 2000). The Trx-like domain specifically interacts with
protein kinase C- and is proposed to play a role in regulating
the function of this kinase and its downstream targets (Witte et
al., 2000).
Here, we present the crystal structure of the N-terminal Trx-
like domain of yGrx3 determined at 1.5 Å resolution. This
report represents the first published structural information for
the Trx-like domain for any member of the monothiol
glutaredoxin/PICOT family.
2. Materials and methods
2.1. Protein expression and crystallization
The yGrx3 open reading frame containing both the Trx-like
and Grx-like domains but lacking the first 35 amino acids (1–
35) was cloned into pET21a and expressed in Escherichia coli
BL21 (DE3) (Novagen) as described previously (Kumanovics
et al., 2008). Briefly, transformants were grown at 310 K until
OD600 reached 0.6 and were induced with 1 mM isopropyl -d-
1-thiogalactopyranoside. Cells were harvested 3 h after
induction and stored at 193 K. Cells were lysed using three
freeze–thaw cycles and soluble protein was extracted with
50 mM Tris–HCl pH 8.0, 5 mM DTT. The extract was loaded
onto a DEAE anion-exchange column (GE Healthcare)
equilibrated with 25 mM Bis-Tris pH 6.0, 5 mM DTT and
eluted with a salt gradient. The fractions containing yGrx3
were further purified by gel filtration using a Superdex 75
column (GE Healthcare) in 50 mM Tris–HCl pH 8.0, 150 mM
NaCl, 5 mM DTT. The final pure protein was concentrated
with the addition of 5% glycerol and stored at 193 K. The
typical yield was 30 mg of protein per litre of cell culture.
Protein purity was checked by SDS–PAGE and MALDI–TOF,
indicating a single species corresponding to 28 120 kDa (the
calculated molecular weight is 28 130 Da upon removal of
Met36).
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Table 1
Crystallographic data and refinement statistics.
Values in parentheses are for the outer shell.
X-ray source APS 22ID (SER-CAT)
Wavelength (Å) 1.0000
No. of frames (high pass/low pass) 400/360
Oscillation range (high pass/low pass) () 0.5/0.5
Crystal-to-detector distance










Solvent content (%) 46
Matthews coefficient (Å3 Da1) 2.3
Mosaicity () 0.44
Resolution range (Å) 32.1–1.50 (1.55–1.50)
Average redundancy 3.5 (1.9)
Average I/(I) 18.7 (2.6)
Total no. of reflections 121469 (1744)
No. of unique reflections 35147 (1646)
Completeness (%) 95.9 (69.1)
Total linear Rmerge (%) 6.2 (34.7)
R value (REFMAC5) (%) 22.5 (30.7)
Rfree value (REFMAC5) (%) 24.9 (30.4)
No. of water molecules 145
Average B factors (chain A/chain B) (Å2) 17.6/17.4
Ramachandran statistics
Residues in most favored regions (%) 92.7
Residues in additional allowed regions (%) 5.8
Residues in generously allowed regions (%) 1.6
Residues in disallowed regions (%) 0
Figure 1
Comparison of yGrx3 Trx domain and hTrx. (a) Sequence alignment of
the crystallized form of yGrx3 (amino acids 37–148) and the complete
sequence of hTrx. The hTrx active-site motif and cis-Pro75 are indicated
by asterisks. (b) Superposition of yGrx3 Trx domain (green) with Cys72 in
green atom type and hTrx (PDB code 1ert; blue) with Cys32 and Cys35 in
blue atom type. The positions of the amino-acid inserts are marked by
arrows.
The final crystallization conditions were optimized from
initial crystallization-condition leads obtained using Crystal
Screen Lite from Hampton Research. Crystals of yGrx3 were
grown under high-salt conditions by the hanging-drop method
at 300 K. Briefly, 2 ml protein solution (11 mg ml1 protein in
50 mM Tris pH 8.0 and 5 mM DTT) was mixed with 2 ml
reservoir solution (0.1 M MOPS pH 7.5, 20 mM ME and 68%
saturated ammonium sulfate).
2.2. Data collection and processing
A yGrx3 crystal was transferred to cryosolvent (60%
ammonium sulfate, 20 mM ME, 0.1 M MOPS and 20%
ethylene glycol) for a few seconds and subsequently flash-
frozen in a liquid N2 vapor stream. Data were collected on the
SER-CAT 22ID beamline at Argonne National Laboratory at
a 1.0000 Å wavelength in two passes: a first pass with a crystal-
to-detector distance of 200 mm and a second pass with a
crystal-to-detector distance of 300 mm, both using a 0.5
oscillation range. The data were indexed and processed using
the HKL-2000 software (Otwinowski & Minor, 1997);
processing parameters and statistics are summarized in Table 1.
2.3. Structure determination and refinement
The structure was solved by molecular replacement using
AMoRe (Navaza, 1994) from the CCP4 system (Collaborative
Computational Project, Number 4, 1994) with the structure of
the reduced form of human thioredoxin (hTrx) as the search
model (PDB code 1ert; Weichsel et al., 1996). The amino-acid
sequence of hTrx is 32% identical to that of the Trx-like
domain of yGrx3 (see Fig. 1a). The initial model was rebuilt
using ARP/wARP (Perrakis et al., 1999)
from the CCP4 suite, while subsequent
interactive molecular-graphics and
crystallographic refinements were carried
out using TURBO FRODO (Roussel &
Cambillau, 1991) and CNS (Brünger et al.,
1998), respectively. The final refinement was
carried out with REFMAC5 (Murshudov et
al., 1997). Superpositions were calculated
using the LSQKAB program (Kabsch,
1976) from the CCP4 suite. Figures were
prepared using TURBO FRODO and
PyMOL (DeLano, 2002).
3. Results and discussion
3.1. Crystallization
The recombinant yGrx3 protein was
cloned from the second start site (encoding
Met36) to the stop codon after determining
that the first start site (encoding Met1) was
not utilized in vivo (N. Dingra & C. Outten,
unpublished data). Furthermore, MALDI–
TOF analysis indicated that Met36 is
removed upon overexpression, as is typi-
cally found when the penultimate amino
acid is relatively small (Pro37 in this case;
Miller, 1975). Crystallization experiments
were performed using this 28 kDa protein
that included both the Trx-like and Grx-like
domains (amino acids 37–285). Two forms
of crystals appeared after about four weeks
under similar conditions. One form was
tetragonal and diffracted poorly, while the
other monoclinic form was superior and its
characterization is the focus of this report.
However, only the Trx-like domain is
present in the monoclinic crystals, with two
protomers per asymmetric unit and amino
acids 37–148 identifiable in the electron
density. The solvent content calculated with
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Figure 2
Representative electron-density map calculated with 2Fo Fc coefficients and contoured at the
1 level.
Figure 3
Stereoview of the putative active site in the Trx-like domain of yGrx3 subunit A (yellow)
superimposed with the human Trx active site (PDB code 1ert; blue). The OMIT map is
contoured at 0.7. Labels are for yGrx3.
the two Trx-like domains in the asymmetric unit was 46%,
which is a typical value, while the solvent content calculated
for two molecules of the Trx-Grx chimera protein was below
0%. Therefore, we believe that the Grx-like domain was
cleaved off during crystallization and the Trx-like domain was
selectively crystallized. Dissociation of the Grx-like domain
during crystallization suggests that the two domains do not
maintain a strong interaction.
Subsequently, the Trx domain (amino acids 36–157) of
yGrx3 was overexpressed (N. Dingra & C. Outten, unpub-
lished data). Its crystallization under similar conditions
yielded both crystal forms. Tetragonal crystals appeared in 2 d
and belonged to the P4 space group with unit-cell parameters
a = 76.42, c = 37.16 Å. Despite good morphology and a size of
0.3 mm, their diffraction only extended to3.5 Å resolution
and thus this crystal form was not investigated further. Crys-
tals of the monoclinic form appeared in
4 d (in contrast to the month needed to
grow them from yGrx3). They were
isomorphic to the crystals obtained from
proteolysis of yGrx3 and had similar
scattering power. Their structure was
essentially the same and thus is not
discussed here in detail.
3.2. Overall structure
Overall, both protomers have good
electron density as shown in Fig. 2. A
sequence alignment of the crystallized
protein with hTrx is given in Fig. 1(a). The
model contains residues 37–148, but both
subunits have a gap in the density in the
putative active-site region (Fig. 1b). In
subunit A the gap is between residues 68
and 71, while in subunit B the gap is
somewhat larger, between residues 68
and 74. This region is located on a
surface-exposed loop. The two protomers
are very similar: the r.m.s. distance
between the C positions is 0.58 Å and
they have similar corresponding
temperature factors.
The yGrx3 Trx-like domain differs
from hTrx by having one amino acid
inserted after position 52 and two amino
acids inserted after position 85 (Fig. 1a).
Despite these differences, the overall fold
of the yGrx3 Trx-like domain remains
very similar to other known thioredoxins
with the typical  topology.
The r.m.s. distance between the C posi-
tions in the Trx-like domain A and in hTrx
(PDB code 1ert) is 1.14 Å.
3.3. Putative active-site region
The signature active-site WCGPC motif found in classical
dithiol thioredoxins is different in the yGrx3 Trx-like domain
and aligns with the sequence WAEPC in the putative active
site. Density is present for the single Cys72 in subunit A, which
is moderately good for the main chain. It is likely that its side
chain populates two conformations with some shift of the main
chain involved. There is no density for C, but there are two
distinct peaks in electron density that are 2.7 Å apart at
positions that approximately correspond to two rotamers of
the thiol. This distance is too short for a simple SH—H2O
contact, which should be 3.2 Å, but some combination of
water/thiol disorder is clearly a possibility. Interestingly, the
two positions of the partially disordered thiol group roughly
correspond to the positions of the two cysteines found in
dithiol thioredoxins (Fig. 3). The position of Pro71 is different
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Figure 4
Sequence alignment of the Trx-like domains of monothiol Grxs in several model organisms.
Highly conserved residues are highlighted in blue and similar residues are shown in pink. The
asterisks indicate the highly conserved residues in the putative active site. The sequences were
aligned using ClustalW2 (Larkin et al., 2007). ScGrx3, Saccharomyces cerevisiae Grx3 (gi|633632);
ScGrx4, S. cerevisiae Grx4 (gi|418432); HsPICOT, Homo sapiens PICOT (gi|6840947); MmPICOT,
Mus musculus PICOT (gi|6840949); DmPICOT, Drosophila melanogaster PICOT (gi|19921242);
CePICOT, Caenorhabditis elegans PICOT (gi|16604139); AtGrxS17, Arabidopsis thaliana GrxS17
(gi|22655350); CaGrx3, Candida albicans Grx3 (gi|46442105); SpGrx4, Schizosaccharomyces
pombe Grx4 (gi|3650389).
Figure 5
Stereoview of electron density for cis-Pro114 contoured at the 1 level.
but well defined, while the residues corresponding to the rest
of the signature motif (Ala69–Glu70) are disordered, indi-
cating flexibility in this part of the structure. The electron
density for Trp68 indicates that it is only slightly shifted in
comparison to the corresponding residue in hTrx. There is a
question whether the catalytic loop disorder might be related
to the proteolysis of yGrx3, since this is a surface loop. This
appeared to be possible when only the structure of the
proteolytically cleaved Trx domain was available. However,
the structure of the recombinant Trx domain also has the
catalytic loop disordered. The recombinant Trx protein
showed limited proteolysis after storage for about a month,
but mass spectrometry showed that none of the major frag-
ments corresponded to a cut in the disordered region.
The lack of conservation of active-site residues is not
limited to the CxxC motif. Asp26 in hTrx, which acts as a
general acid–base catalyst and deprotonates the N-terminal
cysteine in the WCGPC active site, is not present. The residues
corresponding to Asp26 in monothiol Trx proteins are quite
variable (histidine, tyrosine and leucine have been observed;
Fig. 4), so its role is not likely to be significant. The lack of
conservation of the active-site residues suggests that yGrx3
does not catalyze disulfide-bond reduction and that its regu-
latory function involves a different mechanism. However, it is
possible that another cysteine from the Grx-like domain
combines with Cys72 to form a pair of thiols with reducing
capabilities. If that is indeed the case, the flexibility of the
region containing Cys72 suggests that its thiol could penetrate
substrate proteins more efficiently to reach a buried disulfide
bond. For instance, human thymidylate synthase contains a
highly reactive catalytic cysteine in the active-site cavity that
readily forms a covalent bond with oxidized glutathione (L. M.
Gibson, work to be published). To reduce such a buried bond,
an oxidoreductase would have to penetrate the active-site
cavity. This hypothesis can be perhaps verified when the
structural relationship between the domains is established.
Both Trxs and Grxs typically contain a cis-proline located
across from the conserved cysteine residues in the active site.
This cis-proline (Pro114) is conserved in the Trx-like domain
of yGrx3 with excellent electron density as shown in Fig. 5. In
classical Trxs, the cis-proline is required for substrate binding
and is proposed to position the mixed disulfide formed
between Trx and its substrate for attack by the C-terminal
cysteine (Qin et al., 1996). It is unclear whether Pro114 func-
tions in this capacity in the Trx-like domain of yGrx3 since this
domain lacks a second active-site cysteine. However, as
mentioned above it is possible that a cysteine residue in the
Grx-like domain interacts with the monothiol active site of the
Trx-like domain to complete the disulfide-exchange reaction.
The presence of the conserved cis-proline has also been
suggested to prevent metal binding by the redox-active
cysteines in the active site of thioredoxin-fold proteins (Su et
al., 2007). However, several Grxs (including monothiol Grxs
such as yGrx3) are able to bind a 2Fe–2S cluster via active-site
cysteines despite the presence of this conserved cis-proline
(Bandyopadhyay et al., 2008; Johansson et al., 2007; Picciocchi
et al., 2007). Therefore, an alternative possibility is that this
domain functions in metal binding and/or metal transfer to the
Grx-like domain. In fact, the high degree of flexibility in this
putative active-site region is reminiscent of the CxxC metal-
binding loop in metallochaperones (Arnesano et al., 2002).
Since the specific function of the Trx-like domain in yGrx3 has
not been clearly defined, the significance of the conserved cis-
Pro114 in both Fe–S cluster formation and substrate binding
by yGrx3 requires further study.
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